SUVENPHAR Suven Pharmaceuticals Ltd Earnings Reports Announcement 2024 - Q2 Financial Results Suven Pharmaceuticals reported a 12% increase in Q2 revenue to INR 258 Cr., strong growth in its Pharma CDMO business, and positive developments in its strategic initiatives, maintaining a healthy outlook for FY25..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd